ATE470477T1 - Ex-vivo-verfahren zur genzuführung - Google Patents

Ex-vivo-verfahren zur genzuführung

Info

Publication number
ATE470477T1
ATE470477T1 AT06726867T AT06726867T ATE470477T1 AT E470477 T1 ATE470477 T1 AT E470477T1 AT 06726867 T AT06726867 T AT 06726867T AT 06726867 T AT06726867 T AT 06726867T AT E470477 T1 ATE470477 T1 AT E470477T1
Authority
AT
Austria
Prior art keywords
generating
particles
magnetic means
vivo method
therapeutic agent
Prior art date
Application number
AT06726867T
Other languages
English (en)
Inventor
Jon Dobson
Christopher Batich
Original Assignee
Univ Keele
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Keele, Univ Florida filed Critical Univ Keele
Application granted granted Critical
Publication of ATE470477T1 publication Critical patent/ATE470477T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/004—Magnetotherapy specially adapted for a specific therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
AT06726867T 2005-04-22 2006-04-21 Ex-vivo-verfahren zur genzuführung ATE470477T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0508110.4A GB0508110D0 (en) 2005-04-22 2005-04-22 Gene delivery
PCT/GB2006/001477 WO2006111770A2 (en) 2005-04-22 2006-04-21 Gene delivery

Publications (1)

Publication Number Publication Date
ATE470477T1 true ATE470477T1 (de) 2010-06-15

Family

ID=34639915

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06726867T ATE470477T1 (de) 2005-04-22 2006-04-21 Ex-vivo-verfahren zur genzuführung

Country Status (11)

Country Link
US (2) US8232102B2 (de)
EP (1) EP1885450B1 (de)
JP (1) JP5167119B2 (de)
CN (1) CN101193681A (de)
AT (1) ATE470477T1 (de)
AU (1) AU2006238697B2 (de)
CA (1) CA2605533A1 (de)
DE (1) DE602006014821D1 (de)
ES (1) ES2345505T3 (de)
GB (1) GB0508110D0 (de)
WO (1) WO2006111770A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030376A1 (it) 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
JP5282031B2 (ja) * 2006-05-15 2013-09-04 ドミトリィ ビー カーポティン 有機物を含む磁性微粒子
GB0717582D0 (en) * 2007-09-10 2007-10-17 Univ Keele Magnetic transfection device
EP2338520A1 (de) 2009-12-21 2011-06-29 Ludwig Maximilians Universität Konjugat mit Zielfindungsligand und dessen Verwendung
US9249392B2 (en) 2010-04-30 2016-02-02 Cedars-Sinai Medical Center Methods and compositions for maintaining genomic stability in cultured stem cells
US9845457B2 (en) 2010-04-30 2017-12-19 Cedars-Sinai Medical Center Maintenance of genomic stability in cultured stem cells
US9669200B2 (en) 2010-08-06 2017-06-06 Boston Scientific Scimed, Inc. Systems and methods for the treatment of pelvic disorders including magnetic particulates
US9180172B2 (en) 2010-12-15 2015-11-10 Ams Research Corporation Treatment of Peyronies disease
US8979797B2 (en) 2010-12-16 2015-03-17 Ams Research Corporation High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
CN102172410B (zh) * 2011-01-14 2013-08-07 华南理工大学 用于癌症诊断与治疗的靶向纳米粒传输系统的构建方法
EP2861238A4 (de) 2012-06-05 2016-03-16 Capricor Inc Optimierte verfahren zur erzeugung von herzstammzellen aus herzgewebe und deren verwendung in der herztherapie
ES2826203T3 (es) * 2012-06-08 2021-05-17 Ethris Gmbh Suministro pulmonar de ARN mensajero
EP2882445B1 (de) 2012-08-13 2019-04-24 Cedars-Sinai Medical Center Exosomen und mikroribonukleinsäuren zur geweberegeneration
US9951374B2 (en) 2013-02-19 2018-04-24 Wisconsin Alumni Research Foundation Enhanced throughput mineral coatings for optimization of stem cell behavior
AU2015327812B2 (en) 2014-10-03 2021-04-15 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
WO2017123662A1 (en) 2016-01-11 2017-07-20 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
US11351200B2 (en) 2016-06-03 2022-06-07 Cedars-Sinai Medical Center CDC-derived exosomes for treatment of ventricular tachyarrythmias
WO2018057542A1 (en) 2016-09-20 2018-03-29 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
AU2018255346B2 (en) 2017-04-19 2024-05-02 Capricor Inc Methods and compositions for treating skeletal muscular dystrophy
WO2019126068A1 (en) 2017-12-20 2019-06-27 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
WO2020171783A1 (en) * 2019-02-20 2020-08-27 Sabanci Üniversitesi Rotary magnetic actuation system
EP4292660A1 (de) * 2022-06-13 2023-12-20 Fortis GmbH System zur verabreichung eines wirkstoffs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652257A (en) * 1985-03-21 1987-03-24 The United States Of America As Represented By The Secretary Of The Navy Magnetically-localizable, polymerized lipid vesicles and method of disrupting same
US6447499B2 (en) * 1995-07-28 2002-09-10 James R. Gray Use of a polarized field to modify the efficacy of a bioactive agent
US6203487B1 (en) * 1997-12-31 2001-03-20 Thomas Jefferson University Use of magnetic particles in the focal delivery of cells
WO2002000870A2 (en) * 2000-06-26 2002-01-03 Christian Plank Method for transfecting cells using a magnetic field
US6997863B2 (en) * 2001-07-25 2006-02-14 Triton Biosystems, Inc. Thermotherapy via targeted delivery of nanoscale magnetic particles
US20050159682A1 (en) 2002-02-12 2005-07-21 Meiryo Technica Corporation, Ltd Molecule vibrator
US20040136905A1 (en) 2002-10-15 2004-07-15 Kent Thomas B. Magnetically guided particles for radiative therapies
AU2003301322A1 (en) 2002-10-16 2004-05-04 Yoshiro Okami Apparatus for introducing biological material, method of introducing biological material and magnetic support for introducing biological material
US8001977B2 (en) 2005-04-08 2011-08-23 Nanobiomagnetics, Inc. Device for moving magnetic nanoparticles through tissue
CA2538395A1 (en) 2003-09-12 2005-03-24 Bankruptcy Estate Of Ferx, Inc. Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents

Also Published As

Publication number Publication date
CN101193681A (zh) 2008-06-04
AU2006238697A1 (en) 2006-10-26
ES2345505T3 (es) 2010-09-24
US8232102B2 (en) 2012-07-31
GB0508110D0 (en) 2005-06-01
AU2006238697B2 (en) 2011-12-08
JP5167119B2 (ja) 2013-03-21
WO2006111770A2 (en) 2006-10-26
WO2006111770A3 (en) 2007-05-18
US20080286361A1 (en) 2008-11-20
US20120288505A1 (en) 2012-11-15
CA2605533A1 (en) 2006-10-26
EP1885450B1 (de) 2010-06-09
JP2008536907A (ja) 2008-09-11
DE602006014821D1 (de) 2010-07-22
EP1885450A2 (de) 2008-02-13

Similar Documents

Publication Publication Date Title
ATE470477T1 (de) Ex-vivo-verfahren zur genzuführung
MX2013002048A (es) Conjugados, particulas, composiciones y metodos relacionados.
TW200806280A (en) Pharmaceutical compositions
EP2321264A4 (de) Deacetylaseinhibitoren und anwendungen davon
AU2015213336B2 (en) Novel conjugates of CC-1065 analogs and bifunctional linkers
HK1136847A1 (en) Targeted integration into the ppp1r12c locus
PH12014502880A1 (en) Lyophilized therapeutic peptibody formulations
WO2009012176A3 (en) Methods and compositions for treating brain diseases
WO2006127768A3 (en) Microscale micropatterned engineered in vitor tissue
MX2009004862A (es) Estabilizacion de vacunas por liofilizacion.
MY148253A (en) Azaadamantane derivatives and methods of use
TR201900670T4 (tr) İnhalasyon için yöntem ve formülasyon.
MX353608B (es) Anticuerpo modificado en el que el tema que comprende residuos de cisteina esta ligado, conjugado de farmaco de anticuerpo modificado que comprende el anticuerpo modificado y metodo de produccion para el mismo.
MA32161B1 (fr) Formes de rifaximine et utilisations de celles-ci
BR112012026801B8 (pt) conjugados de pirrolobenzodiazepina direcionados, composição farmacêutica, uso dos mesmos para tratamento de uma doença proliferativa ou autoimune e ligante de medicamento
MX2011010673A (es) Formulaciones de nanoparticulas y usos de las mismas.
WO2009006577A3 (en) Compositions and methods for inhibiting ezh2
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
CY1116482T1 (el) Συνθεσεις και μεθοδοι για τη θεραπεια ογκων, ινωσης, και πνευμονικης κυψελιδικης πρωτεϊνωσης
MX2013008702A (es) Composiciones que contienen anticuerpos glicosilados y sus usos.
MX2012012668A (es) Aplicacion de alto cizallamiento en administracion de farmaco.
TN2012000511A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
MX2012004780A (es) Inhibidores de akt.
WO2014008406A3 (en) The bacterial biofilm matrix as a platform for protein delivery
GB2496342A (en) Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties